Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding-status notice and related topic links (Lung cancer and MedlinePlus Genetics), and removed Revision: v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-11T05:13:23.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Site-wide notice about a lapse in government funding and operating status was added, and the page revision updated to v3.4.1. The core study content and criteria remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-04T03:58:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle (Show glossary) and updated UI text, standardizing labels such as 'Last Update Submitted that Met QC Criteria' and capitalization of 'No FEAR Act Data'. The revision/version banner now shows v3.4.0 (replacing v3.3.4); To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:55:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Lung cancer as a topic and related topics including MedlinePlus Genetics. Updated the page revision from v3.3.3 to v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-14T01:56:57.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Deleted Lung cancer and related topics including MedlinePlus Genetics from the study's topics section.
    Difference
    0.2%
    Check dated 2026-01-06T22:45:58.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added related topics sections for Lung cancer and MedlinePlus Genetics to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-30T13:23:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.